PMID- 16234848 OWN - NLM STAT- MEDLINE DCOM- 20060518 LR - 20161124 IS - 0829-8211 (Print) IS - 0829-8211 (Linking) VI - 83 IP - 5 DP - 2005 Oct TI - Hypoxia inducible factor-1: regulation by nitric oxide in posthypoxic microvascular endothelium. PG - 597-607 AB - Microvascular endothelial cells provide a critical regulatory interface between blood constituents and tissue. Hypoxia inducible factor-1 (HIF-1) is a key transcription factor required for expression of hypoxia-dependent genes. We employed a model of hypoxia and reoxygenation (H/R) using the dermal microvascular endothelial cell line HMEC-1 to examine the effects of altered oxygen concentrations on microvascular HIF-1 expression and nitric oxide (NO) formation. Hypoxia increased inducible NO synthase (iNOS) mRNA in a time-dependent manner in HMEC-1. However, endothelial NO synthase mRNA progressively declined during hypoxia. H/R promoted significant increases in cellular nitrite levels that were significantly abrogated by the specific iNOS inhibitor N6-(1-iminoethyl)-L-lysine, di hy drochloride. Exogenous NO promoted stabilization of the alpha subunit of HIF-1 and produced functional DNA binding. Exposure of HMEC-1 to H/R resulted in previously unrecognized biphasic HIF-1alpha stabilization during reoxygenation. When the iNOS gene was silenced through the use of iNOS-specific small interfering RNA, HIF-1alpha stabilization and HIF-1 activation were dramatically diminished, suggesting that inducible NOS-derived NO is a key factor sustaining HIF-1 activation during both hypoxia and reoxygenation. FAU - Natarajan, Ramesh AU - Natarajan R AD - Center for Vascular Inflammation Research, Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Box 980050, Virginia CommonwealthUniversity, Richmond, VA 23298, USA. rnataraj@hsc.vcu.edu FAU - Jones, Drew G AU - Jones DG FAU - Fisher, Bernard J AU - Fisher BJ FAU - Wallace, Timothy J AU - Wallace TJ FAU - Ghosh, Shobha AU - Ghosh S FAU - Fowler, Alpha A 3rd AU - Fowler AA 3rd LA - eng GR - HL-10355/HL/NHLBI NIH HHS/United States GR - R01-HL61359/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - Canada TA - Biochem Cell Biol JT - Biochemistry and cell biology = Biochimie et biologie cellulaire JID - 8606068 RN - 0 (Hypoxia-Inducible Factor 1) RN - 0 (RNA, Messenger) RN - 31C4KY9ESH (Nitric Oxide) RN - EC 1.14.13.39 (Nitric Oxide Synthase Type II) SB - IM MH - Cell Line MH - Electrophoretic Mobility Shift Assay MH - Endothelium, Vascular/enzymology/metabolism/*physiopathology MH - Gene Silencing MH - Humans MH - Hypoxia/*physiopathology MH - Hypoxia-Inducible Factor 1/genetics/metabolism/*physiology MH - Microscopy, Fluorescence MH - Nitric Oxide/*physiology MH - Nitric Oxide Synthase Type II/genetics MH - Protein Binding MH - Protein Transport MH - RNA Interference MH - RNA, Messenger/genetics MH - Transcription, Genetic MH - Transfection EDAT- 2005/10/20 09:00 MHDA- 2006/05/19 09:00 CRDT- 2005/10/20 09:00 PHST- 2005/10/20 09:00 [pubmed] PHST- 2006/05/19 09:00 [medline] PHST- 2005/10/20 09:00 [entrez] AID - o05-047 [pii] AID - 10.1139/o05-047 [doi] PST - ppublish SO - Biochem Cell Biol. 2005 Oct;83(5):597-607. doi: 10.1139/o05-047.